Home
»çÀÌÆ®¸Ê
Contact Us
Eng
¼¾ÅͼҰ³
¿¬±¸¿µ¿ª
¿¬±¸È°µ¿
¿¬±¸½ÇÀû
ÀÚ·á½Ç
°Ô½ÃÆÇ
×
¼¾ÅͼҰ³
Àλ縻
¼³¸³¸ñÀû
¿¬Çõ
Á¶Á÷µµ
Âü¿©¿¬±¸Áø
½Ã¼³ ¹× Àåºñ
¿À½Ã´Â ±æ
¿¬±¸¿µ¿ª
ÀÓ»ó¾à¹°À¯Àüü¿¬±¸ºÎ
ºÐÀھ๰À¯Àüü¿¬±¸ºÎ
¾à¹°À¯Àüü¿¬±¸ Áö¿øºÎ
¿¬±¸È°µ¿
¿¬±¸»ç¾÷
¿¬±¸°³¹ß
¿¬±¸Çù·ÂÁö¿ø
Àη¾缺
¿¬±¸½ÇÀû
ÁßÁ¡¿¬±¸ÀÚ·á
³í¹®½ÇÀû
ÇÐȸ¹ßÇ¥
ƯÇã½ÇÀû
±âŸ½ÇÀû
ÀÚ·á½Ç
º¸µµÀÚ·á
»çÁøÀÚ·á
°ü·Ã»çÀÌÆ®
°Ô½ÃÆÇ
Çà»çÀÏÁ¤
°øÁö»çÇ×
¼¾ÅͼҽÄ
Çаè¼Ò½Ä
Contact Us
Eng
³í¹®½ÇÀû
¿¬±¸½ÇÀû
ÁßÁ¡¿¬±¸ÀÚ·á
³í¹®½ÇÀû
ÇÐȸ¹ßÇ¥
ƯÇã½ÇÀû
±âŸ½ÇÀû
Áö¿ø°úÁ¦º° :
¼±ÅÃÇϱâ
BMRC
BMRC, Japan Fund
BMRC, PRCDM
BMRC, ¼ö¼Ûü
cPMTb
FRONTIER
FRONTIER, PRCDM
NRL
NRL, PRCDM
PRCDM
PRCDM, ¿¬±¸±³¼ö
RCTC
RCTC, BMRC
¿¬µµº° :
¼±ÅÃÇϱâ
2015-International
2015-Domestic
2014-International
2014-Domestic
2013-International
2013-Domestic
2012-International
2012-Domestic
2011-International
2011-Domestic
2010-International
2010-Domestic
2009-International
2009-Domestic
2008-International
2008-Domestic
2007-International
2007-Domestic
2006-International
2006-Domestic
2005-International
2005-Domestic
2004-International
2004-Domestic
2003-International
2003-Domestic
¸ðµÎº¸±â
·
Han EH, Hwang YP, Jeong TC, Lee SS, Shin JG, Jeong HG.
Eugenol inhibit 7,12-dimethylbenz[a]anthracene-induced genotoxicity in MCF-7 cells: Bifunctional effects on CYP1 and NAD(P)H:quinone oxidoreductase.()
FEBS Lett. 2007 Feb 20;581(4):749-56 [
LINK
]
2007-International
·
Lee SJ, van der Heiden IP, Goldstein JA, van Schaik RH.
A new CYP3A5 variant, CYP3A5*11, is shown to be defective in nifedipine metabolism in a recombinant cDNA expression system.()
Drug Metab Dispos. 2007 Jan;35(1):67-71. [
LINK
]
2006-International
·
Shin JG, Kang WK, Shon JH, Arefayene M, Yoon YR, Kim KA, Kim DI, Kim DS, Cho KH, Woosley RL, Flockhart DA.
Possible interethnic differences in quinidine-induced QT prolongation between healthy Caucasian and Korean subjects.()
Br J Clin Pharmacol. 2007 Feb;63(2):206-15. [
LINK
]
2006-International
·
Kim KA, Park PW, Lee OJ, Choi SH, Min BH, Shin KH, Chun BG, Shin JG, Park JY.
Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects.()
Clin Pharmacol Ther. 2006 Dec;80(6):646-56. [
LINK
]
2006-International
·
Gwak J, Cho M, Gong SJ, Won J, Kim DE, Kim EY, Lee SS, Kim M, Kim TK, Shin JG, Oh S.
Protein-kinase-C-mediated {beta}-catenin phosphorylation negatively regulates the Wnt/{beta}-catenin pathway.(PRCDM)
J Cell Sci. 2006 Nov 15;119(Pt 22):4702-9. [
LINK
]
2006-International
·
Yea SS, Jeong HS, Choi CY, Park KR, Oh S, Shin JG, Yun CH.
Inhibitory effect of anethole on T-lymphocyte proliferation and interleukin-2 production through down-regulation of the NF-AT and AP-1.()
Toxicol In Vitro. 2006 Oct;20(7):1098-105. [
LINK
]
2006-International
·
Liu KH, Kim MG, Lee DJ, Yoon YJ, Kim MJ, Shon JH, Choi CS, Choi YK, Desta Z, Shin JG.
Characterization of ebastine, hydroxyebastine, and carebastine metabolism by human liver microsomes and expressed cytochrome P450 enzymes: major roles for CYP2J2 and CYP3A.(NRL)
Drug Metab Dispos. 2006 Nov;34(11):1793-7. [
LINK
]
2006-International
·
Shin JG, Lee KH, Fabio Leonessa, Robert Clarke,David Alastair Flockhart
The disposition of reduced haloperidol and HPP+ Metabolites of haloperidol, is not influenced by P-Glycoprotein()
Kor J Clin Pharmacol Ther. 14(1): 42-50 [LINK ]
2006-Domestic
·
Lee SJ, Shin JG
CYP2C9 Pharmacogenomics: Recent Update and Clinical Relevance.()
Kor J Clin Pharmacol Ther. 14(1): 3-16 [LINK ]
2006-Domestic
·
Liu KH, Moon JK, Seo JS, Park BS, Koo SJ, Lee HS, Kim JH.
Characterization of Pyribenzoxim Metabolizing Enzymes in Rat Liver(PRCDM)
한국독성학회, 22(1), 1-8 [LINK ]
2006-Domestic
[prev]
21
22
23
24
25
26
27
28
29
30
[Next]
Á¦¸ñ
ÀúÀÚ¸í
Áö¿ø°úÁ¦